Masanao Ohashi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Masanao Ohashi has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Hiroshi Sameshima
Department of Obstetrics and Gynecology, Faculty of Medicine University of Miyazaki Miyazaki Japan
2 shared publications H. Hosokawa
Obstetrics, Tonami City Hospital, Tonami, Japan
1 shared publicationK. Mochizuki
Department of Ophthalmology, Kanazawa University School of Medicine, Kanazawa
1 shared publication- Masatoshi Yamaguchi
Division of Clinical Genetics, University of Miyazaki, Miyazaki, Japan
1 shared publication - Munetoshi Miyatake
Faculty of Engineering, University of Miyazaki University of Miyazaki Miyazaki Japan
1 shared publication Ruriko Maruyama
Department of Obstetrics and Gynecology University of Miyazaki, Faculty of Medicine Miyazaki Japan
1 shared publication
Latest Publications
- 17 October 2024
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 50 (12) , 2299-2308
Citrus tamurana Hort. ex Tanaka (Hyuganatsu orange)‐derived arabinogalactan suppresses bone turnover in postmenopausal women: A randomized placebo‐controlled study
Aim: To evaluate Hyuganatsu oranges (Citrus tamurana Hort. Ex Tanaka) derived arabinogalactan for bone turnover, we performed a randomized placebo‐controlled trial.Methods: Sixty‐three postmenopausal women were age‐stratified and randomly assigned to receive arabinogalactan‐rich hyuganatsu juice (study group) or a placebo drink (control group) for 90 days. We measured blood tartrate‐resistant acid phosphatase 5b (TRACP5b), type I procollagen N‐terminal propeptide (P1NP), and other bone turnover biomarker levels at baseline, days 45 and 90 (T90) of the intervention, and day 30 of recovery. Cumulative effects were compared between groups using repeated‐measures linear mixed model analysis. The primary endpoint was the difference between the pre‐ and post‐intervention TRACP5b and P1NP levels.Results: Using repeated measures linear mixed model analysis, the study group had significantly lower TRACP5b and P1NP levels at day 90 than the control group (mean [95% confidence interval]; TRACP5b: 310.0 [269.2–350.9] vs. 386.4 [341.2–431.6] mU/dL; P1NP: 53.7 [48.6–58.7] vs. 70.3 [64.1–76.4] ng/mL), whereas other biomarker levels showed no change.Conclusion: Arabinogalactan‐rich Hyuganatsu juice suppressed bone mineral turnover and potentially improved ovarian hormone deficiency‐induced osteoporosis in postmenopausal women.
- 17 October 2024
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 50 (12) , 2299-2308
Citrus tamurana Hort. ex Tanaka (Hyuganatsu orange)‐derived arabinogalactan suppresses bone turnover in postmenopausal women: A randomized placebo‐controlled study
Aim: To evaluate Hyuganatsu oranges (Citrus tamurana Hort. Ex Tanaka) derived arabinogalactan for bone turnover, we performed a randomized placebo‐controlled trial.Methods: Sixty‐three postmenopausal women were age‐stratified and randomly assigned to receive arabinogalactan‐rich hyuganatsu juice (study group) or a placebo drink (control group) for 90 days. We measured blood tartrate‐resistant acid phosphatase 5b (TRACP5b), type I procollagen N‐terminal propeptide (P1NP), and other bone turnover biomarker levels at baseline, days 45 and 90 (T90) of the intervention, and day 30 of recovery. Cumulative effects were compared between groups using repeated‐measures linear mixed model analysis. The primary endpoint was the difference between the pre‐ and post‐intervention TRACP5b and P1NP levels.Results: Using repeated measures linear mixed model analysis, the study group had significantly lower TRACP5b and P1NP levels at day 90 than the control group (mean [95% confidence interval]; TRACP5b: 310.0 [269.2–350.9] vs. 386.4 [341.2–431.6] mU/dL; P1NP: 53.7 [48.6–58.7] vs. 70.3 [64.1–76.4] ng/mL), whereas other biomarker levels showed no change.Conclusion: Arabinogalactan‐rich Hyuganatsu juice suppressed bone mineral turnover and potentially improved ovarian hormone deficiency‐induced osteoporosis in postmenopausal women.
- Open Access
- 25 November 2022
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 49 (2) , 625-634
Fetal heart rate patterns complicated by chorioamnionitis and subsequent cerebral palsy in Japan
Aim: This retrospective study was performed to investigate whether certain fetal heart rate patterns were associated with subsequent cerebral palsy (CP) in infants with chorioamnionitis at or near term.Methods: We used cases registered by the Japan Obstetric Compensation System for CP, which is a nationwide population‐based database. Among them, 133 infants with chorioamnionitis who were born at ≥34 weeks of gestation were enrolled. All infants underwent magnetic resonance imaging (MRI), and all fetal heart rate charts had been interpreted according to the National Institute of Child Health and Human Development criteria, focusing on antepartum and immediately before delivery.Results: The incidence of CP after chorioamnionitis at ≥34 weeks of gestation was 0.3 per 10 000 in Japan. Between the clinical (24%) and subclinical groups (76%), the incidence of abnormal fetal heart rate patterns did not differ. According to the MRI classification, 88% of the infants with CP showed hypoxic–ischemic encephalopathy. Half of the infants with CP experienced terminal bradycardia, leading to severe acidosis and exclusively to hypoxic–ischemic encephalopathy. In another half, who did not experience bradycardia, 80% had moderate acidosis (pH 7.00–7.20) resulting in hypoxic–ischemic encephalopathy, and the remaining 20% showed non‐acidosis resulting in brain damage other than hypoxic–ischemic encephalopathy. The fetal heart rate patterns before the terminal bradycardia showed that the incidence rates of late deceleration or decreased variability were high (>60%).Conclusion: Fifty percent of pregnant women with chorioamnionitis‐related CP had terminal bradycardia that exclusively resulted in hypoxic–ischemic encephalopathy.
- 25 November 2022
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 49 (2) , 625-634
Open AccessFetal heart rate patterns complicated by chorioamnionitis and subsequent cerebral palsy in Japan
Aim: This retrospective study was performed to investigate whether certain fetal heart rate patterns were associated with subsequent cerebral palsy (CP) in infants with chorioamnionitis at or near term.Methods: We used cases registered by the Japan Obstetric Compensation System for CP, which is a nationwide population‐based database. Among them, 133 infants with chorioamnionitis who were born at ≥34 weeks of gestation were enrolled. All infants underwent magnetic resonance imaging (MRI), and all fetal heart rate charts had been interpreted according to the National Institute of Child Health and Human Development criteria, focusing on antepartum and immediately before delivery.Results: The incidence of CP after chorioamnionitis at ≥34 weeks of gestation was 0.3 per 10 000 in Japan. Between the clinical (24%) and subclinical groups (76%), the incidence of abnormal fetal heart rate patterns did not differ. According to the MRI classification, 88% of the infants with CP showed hypoxic–ischemic encephalopathy. Half of the infants with CP experienced terminal bradycardia, leading to severe acidosis and exclusively to hypoxic–ischemic encephalopathy. In another half, who did not experience bradycardia, 80% had moderate acidosis (pH 7.00–7.20) resulting in hypoxic–ischemic encephalopathy, and the remaining 20% showed non‐acidosis resulting in brain damage other than hypoxic–ischemic encephalopathy. The fetal heart rate patterns before the terminal bradycardia showed that the incidence rates of late deceleration or decreased variability were high (>60%).Conclusion: Fifty percent of pregnant women with chorioamnionitis‐related CP had terminal bradycardia that exclusively resulted in hypoxic–ischemic encephalopathy.
- 1 January 1993
- Published by S. Karger AG in Ophthalmologica
- Vol. 207 (4) , 169-173
Sudden Blindness in the Fourth Month of Pregnancy Led to Diagnosis of Moyamoya Disease
We report a 31-year-old woman in her 4th month of pregnancy who presented with a sudden decrease in her right visual acuity. The right ocular fundus showed marked retinal edema and a cherry-red spot. A cranial computerized tomographic scan showed cerebral infarction. Cerebral angiography disclosed moyamoya disease. Ischemia of the ophthalmic artery due to constriction of the origin of the internal carotid artery and hypercoagulability due to pregnancy have presumably caused visual impairment in this patient.
- 1 January 1993
- Published by S. Karger AG in Ophthalmologica
- Vol. 207 (4) , 169-173
Sudden Blindness in the Fourth Month of Pregnancy Led to Diagnosis of Moyamoya Disease
We report a 31-year-old woman in her 4th month of pregnancy who presented with a sudden decrease in her right visual acuity. The right ocular fundus showed marked retinal edema and a cherry-red spot. A cranial computerized tomographic scan showed cerebral infarction. Cerebral angiography disclosed moyamoya disease. Ischemia of the ophthalmic artery due to constriction of the origin of the internal carotid artery and hypercoagulability due to pregnancy have presumably caused visual impairment in this patient.